Bladder Cancer

FDA Warns Biotech Firm Over Cancer Drug Claims

Physician’s Briefing

FDA Warns Biotech Firm Over Cancer Drug Claims

HealthDay Staff

26 Mar 2026

2 min read

EAU: 90-Day Mortality Rate 9.2 Percent for Emergency Hematuria

Physician’s Briefing

EAU: 90-Day Mortality Rate 9.2 Percent for Emergency Hematuria

17 Mar 2026

1 min read

Perioperative Enfortumab Vedotin + Pembrolizumab Tied to Improved Outcomes With Bladder Cancer

Physician’s Briefing

Perioperative Enfortumab Vedotin + Pembrolizumab Tied to Improved Outcomes With Bladder Cancer

27 Feb 2026

1 min read

Read More

Clinical Briefing Report

clinicalbriefingreport.com